Please assess the completion status of the following clinical trial:

Trial Title: Topical Tranexamic Acid Use on Granulating Wounds Following Mohs Micrographic Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: EARLY_PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* All adult (18 years or older) patients presenting for Mohs micrographic surgery (MMS) for the treatment of melanoma or nonmelanoma skin cancer (NMSC) with a wound that will be healing by granulation~Exclusion Criteria:~* Patients must not be pregnant or breastfeeding.~* Patients must not have a known allergic reaction or sensitivity to TXA~* Patient must not have an international normalized ratio (INR) out of therapeutic range if on warfarin.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Intervention (Type: EXPERIMENTAL): Topical application of tranexamic acid to granulating wound defect status post Mohs micrographic surgery.
- Placebo (Type: PLACEBO_COMPARATOR): Topical application of normal saline to granulating wound defect status post Mohs micrographic surgery.

Based on this trial design, predict the completion outcome and termination type (if applicable).